Complicating the scenario, CD44 is subjected to multiple splicing events and the relative importance of specific CD44 splice variants for particular tumor phenotypes has seemingly remained controversial [25,26,27,28], revealing important discrepancies related to tumor types and stages. This evidence concerns the gene CD44 and neoplasm.